Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Optimized technological method for amplifying recombinant adenovirus by using bioreactor

A bioreactor and recombinant adenovirus technology, applied in biochemical equipment and methods, microorganisms, viruses/phages, etc., to achieve high repeatability and stability, save manpower and material costs, and increase production capacity

Active Publication Date: 2014-11-12
ZHEJIANG PUKANG BIOTECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Hydrolyzed milk protein is a safe and effective medium additive, which has been widely used. There is no report on the amplified adenovirus. How to determine the concentration ratio of it is a direction worth exploring

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Optimized technological method for amplifying recombinant adenovirus by using bioreactor
  • Optimized technological method for amplifying recombinant adenovirus by using bioreactor
  • Optimized technological method for amplifying recombinant adenovirus by using bioreactor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Bioreactor: China Hangzhou AMP Bioengineering Co., Ltd. 10L torrent bioreactor with a working volume of 8L, of which the cell perfusion bag volume is 4L, and the cell density is calculated as 4L. Instrument model: AP20SC;

[0029] Microcarrier: Fibra disk paper carrier 150g (Hangzhou Anpu Bioengineering Co., Ltd.);

[0030] Cells: HEK293, purchased from ATCC, USA;

[0031] Virus: Recombinant type 5 adenovirus vector carrying human papillomavirus oncogene E6 and E7 (AdE6E7) fusion protein gene, self-constructed; inoculation MOI between 20-50;

[0032] Cell growth fluid: DMEM medium containing 10% serum by volume (Gibco, USA);

[0033] Cell maintenance solution: DMEM medium (Gibco, USA) containing a volume concentration of 0.25% hydrolyzed milk protein (Gibco, USA);

[0034] Determination of glucose content in growth fluid:

[0035] Glucose determination kit (glucose oxidase-peroxidase method), Shanghai Rongsheng Biopharmaceutical Co., Ltd.;

[0036] Mix 1ml of the re...

Embodiment 2

[0054] Bioreactor: Bioflo310 cell reactor (USA NBS company); Microcarrier: Fibra disk paper carrier 150g (USA NBS company);

[0055] Virus: recombinant adenovirus type 5 vector; inoculation MOI between 20-50;

[0056] Cell growth solution: DMEM medium containing 10% serum by volume (Gibco);

[0057] Cell maintenance solution: DMEM medium containing 0.25% hydrolyzed milk protein (Gibco);

[0058] Cell culture: 150g of sterilized Fibra disk carrier has been added to the 5L reactor, soaked overnight in phosphate buffer solution PBS with pH 7.2, discarded and added to cell growth medium, and inoculated with HEK293 cells, the inoculation volume is (1.5±0.2 )×10 9 cells to be cultured. The culture parameters are set as follows: pH value 7.1-7.5, temperature 37° C., dissolved oxygen 50-80%, stirring speed 60 rpm. Samples were taken regularly every day to measure glucose consumption, so as to estimate cell growth. Under stable conditions, glucose consumption was linearly related t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the biotechnology field and in particular relates to a comprehensively optimized technological method for amplifying recombinant adenovirus. The method is used for amplifying human embryonic kidney cells (HEK293) by using poly-fiber paper carriers through a bioreactor; in this way, the whole set of process flow of adenovirus replication and amplification is established. The optimized technological method provided by the invention comprises the following steps of: under the condition of comprehensively adapting to type 5 adenovirus replication and amplification system, utilizing a DMEM culture medium containing 10% of blood serum at the cell culture stage, utilizing a DMEM culture medium containing 20% of blood serum in 20 hours after virus inoculation absorption; employing a blood serum-free culture medium added with 0.25% of lactoalbumin hydrolysate at the virus collecting stage, and simultaneously, supplementing 2g / L glucose every 20 hours. The way of batch collection and batch liquid exchange is adopted; and the method enables the optimized process to achieve high virus titer on the basis of reducing the later-stage purification difficulty and meeting the requirements of biological products. Therefore, the optimized process established by the invention an efficient recombinant adenovirus amplification process having excellent repeatability, and is suitable for any bioreactor with the poly-fiber paper as the carriers to amplify the recombinant adenovirus.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a set of optimized process methods for amplifying recombinant adenovirus in a bioreactor used for amplifying recombinant adenovirus. Background technique [0002] Human embryonic kidney (HEK293) cells are packaging cells for adenovirus vectors. Adenoviruses are popular vectors for gene therapy research after retroviruses. Adenovirus vectors are directly introduced into the human body to express target genes for the treatment of malignant tumors, cardiovascular Diseases or some genetic diseases have made gratifying progress; the use of adenovirus vectors to express secreted proteins in packaging cells HEK293, such as protein tyrosine kinase 1C, has also become a way to produce recombinant proteins. In 2004, the world's first gene therapy product "Jinyousheng" was launched in China, which enabled the real application of adenovirus vectors in clinical practice. Therefore, perfecting th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N7/00C12N7/02
Inventor 陈科达吴洁王一虎姜云水庄昉成金素凤高孟张锋李剑波陈刚毛子安毛江森
Owner ZHEJIANG PUKANG BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com